Douglas Merkel to Survival Analysis
This is a "connection" page, showing publications Douglas Merkel has written about Survival Analysis.
Connection Strength
0.029
-
The importance of DNA flow cytometry in node-negative breast cancer. Arch Surg. 1990 Jul; 125(7):886-9.
Score: 0.018
-
Docetaxel combined with trastuzumab is an active regimen in HER-2 3+ overexpressing and fluorescent in situ hybridization-positive metastatic breast cancer: a multi-institutional phase II trial. J Clin Oncol. 2004 Mar 15; 22(6):1071-7.
Score: 0.012